Table 1. Drug list for ATP-TCA with manufacturer and 100% TDC used in the assay and the number of tumours tested with each drug.

Drug or combination	Manufacturer	100% TDC (μM)	Number tested
Cisplatin	Bristol-Myers-Squibba	10.00	27
Doxorubicin	Eli Lillyb	0.92	19
Gemcitabine	Eli Lilly	40.04	26
Paclitaxel	Bristol-Myers-Squibb	15.90	26
Topotecan	GlaxoSmithKlinec	1.78	23
Treosulfan	Medacd	71.86	23
Cisplatin+Gemcitabine	As single agents	As single agents	27
Treosulfan+Gemcitabine	As single agents	As single agents	26

Abbreviation: TDC=test drug concentration.

Some samples had too few cells for all single agents and combinations to be tested.

^aBristol-Myers Squibb Pharmaceuticals Limited, Uxbridge, Middlesex, UK.

^bEli Lilly and Company Limited, Basingstoke, Hampshire, UK.

^cGlaxoSmithKline plc, Brentford, Middlesex, UK.

^dmedac GmbH, Hamburg, Germany.